Skip to main content

FDA OKs Diabetes Drug for Type 2 Heart Failure Risk

heart monitor screen

The FDA granted a new use for diabetes drug Farxiga (dapagliflozin): to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and established heart disease or risk factors for it.



from WebMD Health https://ift.tt/2Jcu9tn
via IFTTT

Comments

Popular posts from this blog

The Future of Autoimmune Disorders: Psoriatic Disease

What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT

Long COVID Experts: ‘So Incredibly Clear What’s at Stake’

It’s estimated that more than a third of people who have had COVID-19 experience neurological complications such as brain fog that persist or develop 3 months after infection. And two thirds of so-called long haulers still have neurological symptoms after 6 months. from WebMD Health https://ift.tt/mx1j6QD via IFTTT